TGFB1 and cancer: Through further exploration of the isoform-specific expression and function of TGFβ across cancer types, isoform-specific TGFβ inhibition offers a novel immunotherapeutic strategy to unleash the adaptive immune system against cancers that fail to respond to current checkpoint inhibitors.